4-(3-tert-butylpyrazol-1-id-5-yl)-6-methoxypyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine;tetrakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene

C102H117F3N32O3Pt4 — CID 160577778

About 4-(3-tert-butylpyrazol-1-id-5-yl)-6-methoxypyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine;tetrakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene

4-(3-tert-butylpyrazol-1-id-5-yl)-6-methoxypyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine;tetrakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene (PubChem CID 160577778) has the molecular formula C102H117F3N32O3Pt4 and a molecular weight of 2676.58 g/mol. Its IUPAC name is 4-(3-tert-butylpyrazol-1-id-5-yl)-6-methoxypyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine;tetrakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene.

Molecular Properties

• Compound Name: 4-(3-tert-butylpyrazol-1-id-5-yl)-6-methoxypyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine;tetrakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene
• PubChem CID: 160577778
• Molecular Formula: C102H117F3N32O3Pt4
• Molecular Weight: 2676.58 g/mol
• Exact Mass: 2674.85
• IUPAC Name: 4-(3-tert-butylpyrazol-1-id-5-yl)-6-methoxypyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine;tetrakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene
• SMILES: COc1cc(-c2[n-]nc3c2C2CCC3(C)C2(C)C)ncn1.COc1cc(-c2cc(C(C)(C)C)n[n-]2)ncn1.COc1cc(-c2cc(C(F)(F)F)n[n-]2)ncn1.Cc1cc(-c2[n-]nc3c2C2CCC3(C)C2(C)C)ncn1.Cc1cc(-c2[n-]nc3c2CCCC3(C)C)ncn1.Cc1cc(-c2[n-]nc3c2CCCC3(C)C)ncn1.Cc1cc(-c2cc(C(C)(C)C)n[n-]2)ncn1.Cc1cc(-c2cc(C)n[n-]2)ncn1.[Pt+2].[Pt+2].[Pt+2].[Pt+2]
• InChI: InChI=1S/C16H19N4O.C16H19N4.2C14H17N4.C12H15N4O.C12H15N4.C9H6F3N4O.C9H9N4.4Pt/c1-15(2)9-5-6-16(15,3)14-12(9)13(19-20-14)10-7-11(21-4)18-8-17-10;1-9-7-11(18-8-17-9)13-12-10-5-6-16(4,15(10,2)3)14(12)20-19-13;2*1-9-7-11(16-8-15-9)12-10-5-4-6-14(2,3)13(10)18-17-12;1-12(2,3)10-5-9(15-16-10)8-6-11(17-4)14-7-13-8;1-8-5-9(14-7-13-8)10-6-11(16-15-10)12(2,3)4;1-17-8-3-5(13-4-14-8)6-2-7(16-15-6)9(10,11)12;1-6-3-8(11-5-10-6)9-4-7(2)12-13-9;;;;/h7-9H,5-6H2,1-4H3;7-8,10H,5-6H2,1-4H3;2*7-8H,4-6H2,1-3H3;5-7H,1-4H3;5-7H,1-4H3;2-4H,1H3;3-5H,1-2H3;;;;/q8*-1;4*+2
• InChIKey: RBJMGPITZBQBAU-UHFFFAOYSA-N
• XLogP: 17.02
• TPSA: 449.85 Ų
• H-Bond Acceptors: 27
• Rotatable Bonds: 11
• Heavy Atoms: 144
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	2676.58
LogP ≤ 5	17.02
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	27

Frequently Asked Questions

What is the IUPAC name of 4-(3-tert-butylpyrazol-1-id-5-yl)-6-methoxypyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine;tetrakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene?

The IUPAC name of 4-(3-tert-butylpyrazol-1-id-5-yl)-6-methoxypyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine;tetrakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene (CID 160577778) is 4-(3-tert-butylpyrazol-1-id-5-yl)-6-methoxypyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine;tetrakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene.

What is the SMILES notation for 4-(3-tert-butylpyrazol-1-id-5-yl)-6-methoxypyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine;tetrakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene?

The canonical SMILES for 4-(3-tert-butylpyrazol-1-id-5-yl)-6-methoxypyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine;tetrakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene is COc1cc(-c2[n-]nc3c2C2CCC3(C)C2(C)C)ncn1.COc1cc(-c2cc(C(C)(C)C)n[n-]2)ncn1.COc1cc(-c2cc(C(F)(F)F)n[n-]2)ncn1.Cc1cc(-c2[n-]nc3c2C2CCC3(C)C2(C)C)ncn1.Cc1cc(-c2[n-]nc3c2CCCC3(C)C)ncn1.Cc1cc(-c2[n-]nc3c2CCCC3(C)C)ncn1.Cc1cc(-c2cc(C(C)(C)C)n[n-]2)ncn1.Cc1cc(-c2cc(C)n[n-]2)ncn1.[Pt+2].[Pt+2].[Pt+2].[Pt+2].

What is the InChIKey of 4-(3-tert-butylpyrazol-1-id-5-yl)-6-methoxypyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine;tetrakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene?

The InChIKey is RBJMGPITZBQBAU-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H19N4O.C16H19N4.2C14H17N4.C12H15N4O.C12H15N4.C9H6F3N4O.C9H9N4.4Pt/c1-15(2)9-5-6-16(15,3)14-12(9)13(19-20-14)10-7-11(21-4)18-8-17-10;1-9-7-11(18-8-17-9)13-12-10-5-6-16(4,15(10,2)3)14(12)20-19-13;2*1-9-7-11(16-8-15-9)12-10-5-4-6-14(2,3)13(10)18-17-12;1-12(2,3)10-5-9(15-16-10)8-6-11(17-4)14-7-13-8;1-8-5-9(14-7-13-8)10-6-11(16-15-10)12(2,3)4;1-17-8-3-5(13-4-14-8)6-2-7(16-15-6)9(10,11)12;1-6-3-8(11-5-10-6)9-4-7(2)12-13-9;;;;/h7-9H,5-6H2,1-4H3;7-8,10H,5-6H2,1-4H3;2*7-8H,4-6H2,1-3H3;5-7H,1-4H3;5-7H,1-4H3;2-4H,1H3;3-5H,1-2H3;;;;/q8*-1;4*+2.

What are the key properties of 4-(3-tert-butylpyrazol-1-id-5-yl)-6-methoxypyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine;tetrakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene?

4-(3-tert-butylpyrazol-1-id-5-yl)-6-methoxypyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine;tetrakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene has a molecular weight of 2676.58 g/mol, XLogP of 17.02, 11 rotatable bonds, 0 hydrogen bond donors, and 27 hydrogen bond acceptors.

Where does this data come from?

All data for 4-(3-tert-butylpyrazol-1-id-5-yl)-6-methoxypyrimidine;4-(3-tert-butylpyrazol-1-id-5-yl)-6-methylpyrimidine;bis(7,7-dimethyl-3-(6-methylpyrimidin-4-yl)-5,6-dihydro-4H-indazol-2-ide);5-(6-methoxypyrimidin-4-yl)-1,10,10-trimethyl-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene;4-methoxy-6-[3-(trifluoromethyl)pyrazol-1-id-5-yl]pyrimidine;4-methyl-6-(5-methylpyrazol-2-id-3-yl)pyrimidine;tetrakis(platinum(2+));1,10,10-trimethyl-5-(6-methylpyrimidin-4-yl)-3-aza-4-azanidatricyclo[5.2.1.02,6]deca-2,5-diene is sourced from PubChem (CID 160577778), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).